NALP1 in vitiligo-associated multiple autoimmune disease. - Wikidata - thesis-toulmin - TriplyDB

NALP1 in vitiligo-associated multiple autoimmune disease.

NALP1 in vitiligo-associated multiple autoimmune disease.

http://www.wikidata.org/entity/Q34003106

about

Interventions for vitiligo Interventions for vitiligo Mutations in NALP12 cause hereditary periodic fever syndromes Modern vitiligo genetics sheds new light on an ancient disease Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*)Pathogen recognition and inflammatory signaling in innate immune defenses The NLR gene family: a standard nomenclature Inflammasomes: too big to miss Function of Nod-like receptors in microbial recognition and host defense NOD-Like Receptors in Infection, Immunity, and Diseases Highlights in pathogenesis of vitiligo Population genetic tools for dissecting innate immunity in humans Current aspects of vitiligo genetics A clear and present danger: inflammasomes DAMPing down disorders of pregnancy Vitiligo--part 1 Structure of the NLRP1 caspase recruitment domain suggests potential mechanisms for its association with procaspase-1 The cell biology of inflammasomes: Mechanisms of inflammasome activation and regulation Holding the inflammatory system in check: NLRs keep it cool Inflammasome-associated nucleotide-binding domain, leucine-rich repeat proteins and inflammatory diseases Activation of inflammasomes requires intracellular redistribution of the apoptotic speck-like protein containing a caspase recruitment domain Differential splicing of the apoptosis-associated speck like protein containing a caspase recruitment domain (ASC) regulates inflammasomes CARD8 and NLRP1 undergo autoproteolytic processing through a ZU5-like domain The inflammasome adaptor ASC regulates the function of adaptive immune cells by controlling Dock2-mediated Rac activation and actin polymerization The NALP1 inflammasome controls cytokine production and nociception in a rat fracture model of complex regional pain syndrome Anthrax lethal toxin activates the inflammasome in sensitive rat macrophages Melanocytes and their diseases The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis Genetics of Vitiligo.Vitiligo in adults and children.Nod-like receptors: cytosolic watchdogs for immunity against pathogens.Genetic variation of promoter sequence modulates XBP1 expression and genetic risk for vitiligo.IL-1beta processing in host defense: beyond the inflammasomes.Susceptibility to anthrax lethal toxin-induced rat death is controlled by a single chromosome 10 locus that includes rNlrp1 Epigenetics in human autoimmunity. Epigenetics in autoimmunity - DNA methylation in systemic lupus erythematosus and beyond.Genetic analysis of long-lived families reveals novel variants influencing high density-lipoprotein cholesterol.Potential of IL-1, IL-18 and Inflammasome Inhibition for the Treatment of Inflammatory Skin Diseases.Light, including ultraviolet.A Multicenter Collaborative Study by the Korean Society of Vitiligo about Patients' Occupations and the Provoking Factors of Vitiligo Autoimmune polyendocrine syndromes: clues to type 1 diabetes pathogenesis.What causes alopecia areata?

P2860

Q24187979-6F8063EF-B37F-4E1B-B6DA-4D57FC54F89C Q24240527-7B6C30C4-232C-4091-82B6-EF12A11B6E2A Q24308730-53D7A49A-B830-4B42-A495-BDE2AF7E9AA0 Q24618105-BED4FE81-70C5-4DAD-9CBB-542608352C19 Q24631660-DFF1CAE9-BD4F-4D4A-B869-8904D7E9F5D2 Q24643034-1915361B-D0E9-4894-B668-B28522C4CEEB Q24645445-93FA02F9-5B5B-4C0E-B3EA-B76EB97085D1 Q24647337-A2F2F1F6-9D09-41F7-8060-BF0D1D3F39CE Q24647448-2F76920C-228E-4FDE-98A7-94E7E69615BC Q26775253-365145D7-965C-428B-987D-C0D68676FD9C Q26851509-9B1B3190-6A6D-4A80-A3CB-EB5DD6190993 Q27001032-AAD827FD-A730-4F99-8153-F8994FCC34EF Q27003993-97248926-3500-41AD-A08B-33103A5934B3 Q27007734-3F4C7CA0-C5DC-4240-9F56-ECAB85B95315 Q27028001-04095F74-7AC9-4FA1-9C8B-006F19F01CC5 Q27676879-4BD0AF39-AD08-4FCE-8509-4C093285E328 Q28079360-00911E5F-4E9B-45D6-9C1A-6B8E9DE2732E Q28081065-93852E0A-E980-412D-B25C-1D54AD99D8FB Q28267534-A6320239-6FAF-4C0D-A11C-C59B8B2F4B53 Q28387719-B1503B0F-8B8B-43BE-B575-0CA4C1985670 Q28396225-0A6060AC-C000-4BCF-BF2C-4156CC1C59AF Q28477871-1819A293-D650-400D-8D41-F06E07326B43 Q28511079-042C9426-7CD0-46C1-BD84-188435B54E48 Q28568698-0DEC09C7-8A2D-42BD-A169-DB83ABD3A1CF Q28572221-CBF4A116-0A75-475F-8E1D-31C67433FC1B Q28658506-AAC05D7C-94A5-423F-95C7-A14B635AD4BB Q29617049-473625A0-6B2F-4DAE-BCB0-C377D6A798C5 Q30235209-688167A4-CF52-4476-BFE1-EB91DC524478 Q31004500-87769EA6-1C1C-49D7-BA4D-9E15C353110D Q33312855-FFA3C216-BC47-44FF-A6C0-626C35A173EA Q33471405-0599715F-8DDB-4E15-BDAC-3A5BD6733274 Q33535878-748354B1-41D7-456D-B5B6-11B1015C55B5 Q33587520-3C53276C-CB2E-4E35-95A3-9844D7680A50 Q33643660-73DCA2AB-0541-4F6A-9D46-8DEDE3E61727 Q33703175-94C4BF2D-9E64-45D4-9E61-A14C7ADE1C89 Q33710807-FC4CEA2A-9B15-46D3-80A6-8CBFE77AF17D Q33716728-5072DB2C-947A-4D06-8443-EEEB548A963F Q33801996-7FBAB07A-418C-4B36-90D8-844A7A33161B Q33811669-3F756ABB-EF62-4D23-A0BA-B1A51FA8AA57 Q33889367-D952616C-CB13-4D08-93FA-E6AF952F96E1

P2860

NALP1 in vitiligo-associated multiple autoimmune disease.

http://www.wikidata.org/entity/Q34003106

description

2007 nî lūn-bûn

@nan

2007 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի մարտին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

NALP1 in vitiligo-associated multiple autoimmune disease.

@ast

NALP1 in vitiligo-associated multiple autoimmune disease.

@en

NALP1 in vitiligo-associated multiple autoimmune disease.

@nl

type

label

NALP1 in vitiligo-associated multiple autoimmune disease.

@ast

NALP1 in vitiligo-associated multiple autoimmune disease.

@en

NALP1 in vitiligo-associated multiple autoimmune disease.

@nl

prefLabel

NALP1 in vitiligo-associated multiple autoimmune disease.

@ast

NALP1 in vitiligo-associated multiple autoimmune disease.

@en

NALP1 in vitiligo-associated multiple autoimmune disease.

@nl

P1433

Q34003106-BC0C0CAF-EEA9-416B-9453-5A79668FB745

P1476

Q34003106-1AC676A0-6988-4AC8-9DA5-1EB4A1F24CF6

P2093

Q34003106-0114B917-8146-4CF8-BD26-DDD373B4C05F

Q34003106-9CDBA9CF-C533-4902-9F06-CCB5E3721125

Q34003106-A94F86B6-1CC7-49F8-81D8-96BAA1F1B820

Q34003106-D2D4BADA-7AF2-4975-8B37-A3B636BD4DA8

Q34003106-D435636D-A2DD-4744-977D-7DA5A1902A02

Q34003106-E996A196-0291-491E-B9D2-A8914213F2A3

Q34003106-EF0E7402-D84A-4172-84E7-BB46EDC2C9BF

Q34003106-FE3C03E1-7C8B-4D35-B187-1588E01566B3

P304

Q34003106-4011E840-D011-450E-B787-B48B2B6E5CFC

P31

Q34003106-87452446-C33E-4C70-AA35-2E68CB3DCA33

P356

Q34003106-26BF7B3B-18C7-42DE-8B38-A04A96BC3617

P407

Q34003106-7AF8CE35-A09E-44A7-A970-94AC9852E69E

P433

Q34003106-7BC85FAB-6520-4298-AB72-3FB1C59F93AA

P478

Q34003106-2CE03506-B87F-4416-BBD3-BE1443F6C8BA

P577

Q34003106-969069A7-8984-4B93-8225-18D9E3AEB768

P5875

Q34003106-738ABC27-D391-4AD6-9B5B-476A296EC608

P698

Q34003106-5620D31E-4472-4B19-AAA2-3C0E7EE6986C

P356

P1433

The New England Journal of Medicine

P1476

NALP1 in vitiligo-associated multiple autoimmune disease.

@en

P2093

Christina M Mailloux

http://www.w3.org/2001/XMLSchema#string

Dorothy C Bennett

http://www.w3.org/2001/XMLSchema#string

Greggory LaBerge

http://www.w3.org/2001/XMLSchema#string

Katherine Gowan

http://www.w3.org/2001/XMLSchema#string

Pamela R Fain

http://www.w3.org/2001/XMLSchema#string

Richard A Spritz

http://www.w3.org/2001/XMLSchema#string

Sheri L Riccardi

http://www.w3.org/2001/XMLSchema#string

Ying Jin

http://www.w3.org/2001/XMLSchema#string

P304

1216-1225

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA061592

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

356

http://www.w3.org/2001/XMLSchema#string

P577

2007-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6430449

http://www.w3.org/2001/XMLSchema#string

P698

17377159

http://www.w3.org/2001/XMLSchema#string